{"id":"https://openalex.org/W2124410285","doi":"https://doi.org/10.1345/aph.18422","title":"Factors Influencing the Incidence of Lamotrigine-Related Skin Rash","display_name":"Factors Influencing the Incidence of Lamotrigine-Related Skin Rash","alternate_titles":[],"publication_year":1999,"publication_date":"1999-10-01","ids":{"openalex":"https://openalex.org/W2124410285","doi":"https://doi.org/10.1345/aph.18422","mag":"2124410285","pmid":"https://pubmed.ncbi.nlm.nih.gov/10534214"},"language":"en","primary_location":{"id":"doi:10.1345/aph.18422","doi":"https://doi.org/10.1345/aph.18422","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.18422","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2124410285"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079729727","display_name":"Ian Chi Kei Wong","orcid":"https://orcid.org/0000-0001-8242-0014","observed_orcids":["https://orcid.org/0000-0001-8242-0014"]},"institutions":[{"id":"https://openalex.org/I139894009","display_name":"University of Bradford","ror":"https://ror.org/00vs8d940","country_code":"GB","type":"education","lineage":["https://openalex.org/I139894009"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ian CK Wong","raw_affiliation_strings":["Ian CK Wong PhD MRPharmS, Lecturer in Pharmacy Practice, School of Pharmacy, University of Bradford, Bradford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ian CK Wong PhD MRPharmS, Lecturer in Pharmacy Practice, School of Pharmacy, University of Bradford, Bradford, UK","institution_ids":["https://openalex.org/I139894009"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112822348","display_name":"George E. Mawer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George E Mawer","raw_affiliation_strings":["George E Mawer PhD FRCP, Professor Emeritus of Clinical Pharmacology, University of Manchester, Manchester, UK; Consultant Physician, David-Lewis Centre for Epilepsy, Cheshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George E Mawer PhD FRCP, Professor Emeritus of Clinical Pharmacology, University of Manchester, Manchester, UK; Consultant Physician, David-Lewis Centre for Epilepsy, Cheshire, UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035657409","display_name":"Josemir W. A. S. Sander","orcid":"https://orcid.org/0000-0001-6041-9661","observed_orcids":["https://orcid.org/0000-0001-6041-9661"]},"institutions":[{"id":"https://openalex.org/I4210151618","display_name":"National Hospital for Neurology and Neurosurgery","ror":"https://ror.org/048b34d51","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1340918713","https://openalex.org/I4210151618"]},{"id":"https://openalex.org/I4405260083","display_name":"UCL Queen Square Institute of Neurology","ror":"https://ror.org/0370htr03","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I4405260083","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Josemir WAS Sander","raw_affiliation_strings":["Josemir WAS Sander PhD MD, Professor of Neurology, Institute of Neurology; Consultant Neurologist, National Hospital for Neurology and Neurosurgery, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Josemir WAS Sander PhD MD, Professor of Neurology, Institute of Neurology; Consultant Neurologist, National Hospital for Neurology and Neurosurgery, London, UK","institution_ids":["https://openalex.org/I4210151618","https://openalex.org/I4405260083"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":3.936,"has_fulltext":false,"cited_by_count":136,"citation_normalized_percentile":{"value":0.93735499,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"33","issue":"10","first_page":"1037","last_page":"1042"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.014999999664723873,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-induced-rash","display_name":"drug rash","score":0.6909999847412109},{"id":"https://openalex.org/keywords/starting-dose","display_name":"starting dose","score":0.6620000004768372},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.7319999933242798},{"id":"https://openalex.org/keywords/risk-factors","display_name":"risk factors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.6209999918937683},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7689999938011169},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5569999814033508},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.5479999780654907},{"id":"https://openalex.org/keywords/manufacturer-recommendations","display_name":"manufacturer recommendations","score":0.625}],"concepts":[{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.9697793126106262},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.93468177318573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8618302345275879},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.7067091464996338},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.49431824684143066},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3876228928565979},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3650319576263428},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.11932539939880371},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004739","descriptor_name":"England","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1345/aph.18422","doi":"https://doi.org/10.1345/aph.18422","is_oa":false,"landing_page_url":"https://doi.org/10.1345/aph.18422","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:10534214","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10534214","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:81142","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/81142/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ANNALS OF PHARMACOTHERAPY , 33 (10) 1037 - 1042. (1999)","raw_type":"Article"},{"id":"pmh:oai:hub.hku.hk:10722/132920","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10722/132920","pdf_url":null,"source":{"id":"https://openalex.org/S4377196271","display_name":"The HKU Scholars Hub (University of Hong Kong)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I889458895","host_organization_name":"University of Hong Kong","host_organization_lineage":["https://openalex.org/I889458895"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W67334193","https://openalex.org/W185999202","https://openalex.org/W1530850918","https://openalex.org/W1905289128","https://openalex.org/W1965974607","https://openalex.org/W1972578648","https://openalex.org/W1974098973","https://openalex.org/W1975482049","https://openalex.org/W1976470591","https://openalex.org/W1976810263","https://openalex.org/W1979083613","https://openalex.org/W1989801730","https://openalex.org/W1998982477","https://openalex.org/W2001997630","https://openalex.org/W2019134598","https://openalex.org/W2036549873","https://openalex.org/W2039674635","https://openalex.org/W2067488182","https://openalex.org/W2069566385","https://openalex.org/W2070435801","https://openalex.org/W2085156144","https://openalex.org/W2118202495","https://openalex.org/W2124735434","https://openalex.org/W2198453011","https://openalex.org/W2403810829","https://openalex.org/W2797597138"],"related_works":["https://openalex.org/W2169199114","https://openalex.org/W1973862856","https://openalex.org/W1999661391","https://openalex.org/W2065130340","https://openalex.org/W2259464463","https://openalex.org/W2086074106","https://openalex.org/W3005007654","https://openalex.org/W2130440545","https://openalex.org/W2523382097","https://openalex.org/W3159586505"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2,11],"the":[3,12,20,23,28,33,53,89,163,176,193,207,216,222,236,262,272,285,295,304],"incidences":[4,83,110],"of":[5,25,27,36,80,84,91,104,111,136,146,156,178,196,218,228,255,265,274,287],"serious":[6,112,179,288],"and":[7,18,77,87,113,123,166,203,257],"nonserious":[8,114],"lamotrigine-related":[9,16,59,197,219],"rash,":[10,17,180,198],"risk":[13,56,135,145],"factors":[14,57,68],"for":[15,58],"evaluate":[19],"impact":[21],"on":[22],"incidence":[24,177,195,217,273,286],"rash":[26,60,85,115,138,220,289],"manufacturer's":[29,164],"recommendation":[30,90],"to":[31,121,128,151,162,184,211,234],"reduce":[32,235],"starting":[34,78,94,154,226,237,263,296],"dose":[35,79,95,155,227,238,264],"lamotrigine.":[37,81],"METHODS:":[38],"This":[39],"was":[40,158,168,189],"a":[41,143,169,213,240,268],"retrospective":[42],"case":[43],"record":[44],"survey":[45],"at":[46,133],"five":[47],"tertiary":[48],"referral":[49],"epilepsy":[50,73],"centers":[51],"in":[52,93,160,175,192,215,284],"UK.":[54],"The":[55,66,82,109,153,253],"were":[61,70,96,107,116,132,140],"identified":[62],"by":[63,98,293],"logistic":[64],"regression.":[65],"independent":[67],"tested":[69],"gender,":[71],"age,":[72],"type,":[74],"concurrent":[75],"medication,":[76],"before":[86,202],"after":[88,206],"reduction":[92,171,191,214,283],"compared":[97],"chi2":[99],"analysis.":[100],"RESULTS:":[101],"A":[102],"total":[103],"1050":[105],"patients":[106],"included.":[108],"1.1%":[117],"(95%":[118,125,148],"CI":[119,126,149],"0.5%":[120],"1.8%)":[122],"7%":[124],"5.5%":[127],"8.6%),":[129],"respectively.":[130],"Females":[131],"higher":[134],"developing":[137],"than":[139],"males,":[141],"with":[142,199,246],"relative":[144],"1.8":[147],"1.2":[150],"2.8).":[152],"lamotrigine":[157,229,266],"reduced":[159],"response":[161],"recommendation,":[165],"there":[167,188],"significant":[170,269,282],"(p":[172],"=":[173],"0.045)":[174],"from":[181,232,303],"1.5%":[182],"(12/805)":[183],"0%":[185],"(0/245).":[186],"However,":[187],"no":[190],"overall":[194],"63/805":[200],"(8%)":[201],"23/245":[204],"(9%)":[205],"recommendation.":[208],"CONCLUSIONS:":[209],"Failure":[210],"detect":[212],"since":[221],"new":[223],"(reduced)":[224],"recommended":[225],"may":[230],"arise":[231],"failure":[233],"below":[239],"critical":[241],"threshold":[242],"level,":[243],"incomplete":[244],"compliance":[245],"current":[247],"recommendations,":[248],"or":[249],"insufficient":[250],"sample":[251],"size.":[252],"results":[254],"this":[256,277],"other":[258],"studies":[259],"show":[260],"that":[261,281],"is":[267],"factor":[270],"affecting":[271],"rash;":[275],"furthermore,":[276],"study":[278],"also":[279],"shows":[280],"can":[290],"be":[291],"achieved":[292],"reducing":[294],"dose.":[297],"Therefore,":[298],"clinicians":[299],"should":[300],"not":[301],"deviate":[302],"recommendations.":[305]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2124410285","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
